Navigation Links
STEMCELL Technologies Introduces AggreWell™400 for Standardized Embryonic Stem Cell and Induced Pluripotent Stem Cell Research
Date:8/20/2008

STEMCELL Technologies' AggreWell™400 plate is a novel tool for standardizing the generation of uniform embryoid bodies.

Vancouver, British Columbia (PRWEB) August 20, 2008 -- http://www.stemcell.com [STEMCELL Technologies], a leader in specialty cell culture media, cell separation products and ancillary reagents for stem cell research, today announced the release of the AggreWell™400 plates, a revolutionary tool for researchers using embryonic and induced pluripotent stem cells (ESC and iPSC).

"The AggreWell™400 plate standardizes a critical step in the development of embryonic and induced pluripotent stem cells into clinically-relevant mature cells," says Clive Glover, Ph.D., STEMCELL Technologies' Product Manager for Pluripotent Stem Cell Biology. "These cells have been difficult to work with because of the lack of standardized methods to culture and differentiate them. The AggreWell™400 plate is the latest product in STEMCELL Technologies' portfolio that addresses the need for standardized methods and tools for stem cell research."

Many protocols for inducing the development ESC and iPSC into clinically relevant cell types rely on the formation of embryoid bodies (EBs), which are 3-dimensional aggregates of cells. In addition to being labor-intensive, current methods for making EBs results in aggregates that are inconsistent in size and shape, leading to inefficient differentiation.

In contrast, researchers using the AggreWell™400 plates are able to control the size of EBs, enabling them to optimize their differentiation protocols. Additionally the AggreWell™400 plates allow stem cell scientists to easily create large quantities of uniformly-sized EBs

For more information about the AggreWell™400 plates, visit

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Neuralstem Responds to Incorrect StemCells, Inc. Release on Patents
2. VirtualHealth Technologies, Inc., Announces That Its Associate, Private Access, Will Be Partnering with Genetic Alliance To Accelerate Medical Research While Protecting Privacy
3. VirtualHealth Technologies, Inc., Announces Its Associate, Private Access, Appoints Marc Kirshbaum as President & COO
4. Frost & Sullivan Honors ConforMIS for Its Contribution to Personalized Care Through its Customized Implant Development Technologies
5. Wound Management Technologies, Inc. Announces Clarification of Eprint Viewing of Case Report in Advances in Skin and Wound Journal
6. IDE Technologies Signs Contract Worth Over 100 Million Euros to Supply a Desalination Plant to Australia
7. China Medical Technologies Announces Concurrent Offerings of $150 Million of Convertible Senior Notes and Purchased ADSs Pursuant to ADS Issuance and Repurchase Agreements
8. Free White Paper: Hospital Tests Patient Lift Technologies; Improves Quality of Care
9. Wound Management Technologies, Inc. Announces Products to Be Registered in Taiwan
10. On-X Life Technologies Significantly Reduces Study Management Costs with TEMPO from Clinipace
11. VNUS Medical Technologies Reports Second-Quarter 2008 Results: 25% Growth in Net Product Revenues and 38% Growth in Unit Sales

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...7 GSI Group Inc. (Pink S...ion technology products and semiconductor systems,...pany,s shareholders has been scheduled for Friday,...ting will be announced in due course. As previous...otice from Stephen Bershad, a holder of greater th...
(Date:11/27/2009)...PRNewswire-FirstCall/ -- The Gymboree Corporation .../COO, will present at the NASDAQ OMX 23rd Investor... in London, England, on Wednesday, December 2, 200...oadcast of The Gymboree Corporation,s presentation...com, click on "Our Company" at the bottom of the p...
(Date:11/27/2009)...Holdings has announced that it has become a nation... largest nonprofit organizations dedicated to arth... Delray Beach, FL (Vocus) Nove...CHO), a company specializing in the marketing and ...s, has announced today that is has become a nation...
(Date:11/27/2009)...alth™ announced today that Spectrum Health (... Enterprise orthopedic templating solution and its... (PRWEB) November 27, 2009 -- Voyant ... (Grand Rapids, Michigan) has licensed its TraumaC...ts TraumaCad Extend workflow solution, to allow it...
(Date:11/26/2009)...wswire/ -- With cold and flu season upon us, it,s ...to control the spread of infections and avoid illn...ep ourselves healthy, but to avoid transmitting il... CIC (certified in infection-control), nursing dir...h at Hospital for Special Surgery (HSS) in Manhatt...
Breaking Medicine News(10 mins):Health News:GSI Group Calls Shareholders Meeting 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4
...developed a gel that it says can treat hypogonadis...dism is a condition that causes reduced libido, er...y, and irritability. Like women who grow l... male libido and sexual function, as well as muscl...
...nown for its religious fervour, is emerging as a h...s as Astrology Doctors . Many claim that t... kidney-related problems and others, with their ge...tones are prescribed for patients after studying t...
...as found that diabetes is associated with decrease... developing heart disease . The study, pub...e JAMA/Archives journals, shows that men and women...ut diabetes. Globalization of the Western ...
...search team has identified a gene that, when mutat...rited blindness in babies . Scientists at ...experts from other centres around the world, disco...rs congenital amaurosis (LCA), comes at a time of ...
...iyo Mori said Monday she had confidence in herself...onal Japanese women who are often seen as timid. ... to Japan," Mori, 20, told her first news conferen...Fuji last month became the second Japanese to be c...
...cessfully eased the symptoms of Parkinson's diseas...splants . During the course of study, publ...f Sciences, the scientists isolated stem cells fro...monkeys with a severe form of chemically induced P...
Other Medicine News:Health News:Is Gemstone-therapy an Alternative to Treat Illness? 2Health News:Diabetes Reduces Life Expectancy, Increases Heart Disease Risk 2Health News:New Gene Discovery Raises Hope for Childhood Blindness Cure 2Health News:New Gene Discovery Raises Hope for Childhood Blindness Cure 3
(Date:11/27/2009)..., BLOOMINGTON, Minn, Nov. 27 AC...dical image management software, data migration to...United States Patent and Trademark Office has appr...ion Format within a Computer Network." Acuo Techno...rtfolio of intellectual property. In general, the ...
(Date:11/25/2009)... , WESTON, Fla., Nov. 25 /PRNewswire-Firs... Sheets: ASFX) ("the Company") is pleased to annou... production management office in Shanghai, China. ...d, providing an essential gateway for the developm...d safety products for children and adults to be di...
(Date:11/25/2009)... , PHILADELPHIA, Nov. 25 /PRNewswire-First...t Dr. Michael J. McKelvey, the Company,s President...ve Vice President and CFO, are scheduled to presen...ference at 1:30 PM EST on December 1, 2009 in New ...access the presentation by visiting the Company,s ...
Breaking Medicine Technology:Acuo Technologies Announces Patent for Asset Communication Format Within a Computer Network 2American Scientific Resources Inc. Opens Shanghai Location 2ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2Meridios Ltd Selected as a Nationwide CMS Qualified Registry to Report Healthcare Quality Measures 48726 1Meridios Ltd Selected as a Nationwide CMS Qualified Registry to Report Healthcare Quality Measures 48726 2Actuaries Urge Need for Risk Management and Continuity Planning With H1N1 Pandemic 48724 1Actuaries Urge Need for Risk Management and Continuity Planning With H1N1 Pandemic 48724 2Actuaries Urge Need for Risk Management and Continuity Planning With H1N1 Pandemic 48724 3Aviation Law Expert Offers Guidance on How Families of Air France Flight 447 May Seek Compensation from Airline 48721 1Aviation Law Expert Offers Guidance on How Families of Air France Flight 447 May Seek Compensation from Airline 48721 2
...cus Attention on a New Ab...ation Frontiers, Inc.,today announced that two stu...trial fibrillation catheter ablation system were p... a premier meeting for physicians that,treat cardi...versity Clinic at Regensburg, Germany,presented re...
...ences, Inc. (Nasdaq: PBIO ) ("PBI" and "the Compa...ase II Small Business Innovation Research,(SBIR) G...s of Health,(NIH). The Grant will help fund contin...and commercialization of novel, automated, and rep... important protein biomarkers,subcellular molecula...
Other Medicine Technology:Studies of an Innovative Catheter Ablation System for Atrial Fibrillation Reveal Excellent Outcomes, Safety Profile and Fast Procedure Times 2Studies of an Innovative Catheter Ablation System for Atrial Fibrillation Reveal Excellent Outcomes, Safety Profile and Fast Procedure Times 3Pressure BioSciences, Inc. Announces $850,000 NIH SBIR Phase II Award for the Development of a New PCT-dependent System for Improved Biomarker Discovery, Diagnostics, and Drug Discovery 2Pressure BioSciences, Inc. Announces $850,000 NIH SBIR Phase II Award for the Development of a New PCT-dependent System for Improved Biomarker Discovery, Diagnostics, and Drug Discovery 3Pressure BioSciences, Inc. Announces $850,000 NIH SBIR Phase II Award for the Development of a New PCT-dependent System for Improved Biomarker Discovery, Diagnostics, and Drug Discovery 4
SureStep Benzodiazepines (BZO 200)
SureStep Propoxyphene (PPX)
SureStep Tricyclic antidepressants (TCA)
THC/COC/MOP/AMPII/MAMPII/BZO200
Medicine Products: